This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
J Abramowitz , E Foa (2000). Does comorbid major depressive disorder influence outcome of exposure and response prevention for OCD? Behavior Therapy 31, 795–800.
JS Abramowitz , ME Franklin , SA Schwartz , JM Furr (2003). Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology 71, 1049–1057.
LR Baxter Jr., JM Schwartz , KS Bergman , MP Szuba , BH Guze , JC Mazziotta , A Alazraki , CE Selin , HK Ferng , P Munford , ME Phelps (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry 49, 681–689.
DW Black , P Monahan , J Gable , N Blum , G Clancy , P Baker (1998). Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. Journal of Clinical Psychiatry 59, 420–425.
C Blanco , M Olfson , DJ Stein , HB Simpson , MJ Gameroff , WH Narrow (2006). Treatment of obsessive-compulsive disorder by U.S. psychiatrists. Journal of Clinical Psychiatry 67, 946–951.
AW Buchanan , KS Meng , IM Marks (1996). What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder? Anxiety 2, 22–27.
J Cottraux , I Note , SN Yao , S Lafont , B Note , E Mollard , M Bouvard , A Sauteraud , M Bourgeois , J-F Dartigues (2001). A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychotherapy and Psychosomatics 70, 288–297.
E de Haan , P van Oppen , AJ van Balkom , P Spinhoven , KA Hoogduin , R Van Dyck (1997). Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy. Acta Psychiatrica Scandinavica 96, 354–361.
D Denys , H Burger , H van Megen , F de Geus , H Westenberg (2003). A score for predicting response to pharmacotherapy in obsessive-compulsive disorder. International Clinical Psychopharmacology 18, 315–322.
E Foa , J Abramowitz , M Franklin , MJ Kozak (1999). Feared consequences, fixity of belief, and treatment outcome in patients with obsessive-compulsive disorder. Behavior Therapy 30, 717–724.
EB Foa , JB Grayson , GS Steketee , HG Doppelt , RM Turner , PR Latimer (1983 a). Success and failure in the behavioral treatment of obsessive-compulsives. Journal of Consulting and Clinical Psychology 51, 287–297.
EB Foa , MR Liebowitz , MJ Kozak , S Davies , R Campeas , ME Franklin , JD Huppert , K Kjernisted , V Rowan , AB Schmidt , HB Simpson , X Tu (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 162, 151–161.
BS Gershuny , L Baer , MA Jenike , WE Minichiello , S Wilhelm (2002). Comorbid posttraumatic stress disorder: impact on treatment outcome for obsessive-compulsive disorder. American Journal of Psychiatry 159, 852–854.
WK Goodman , LH Price , SA Rasmussen , C Mazure , RL Fleischmann , CL Hill , GR Heninger , DS Charney (1989). The Yale–Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry 46, 1006–1011.
M Hamilton (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology 32, 50–55.
M Hamilton (1960). A Rating Scale for Depression. Journal of Neurology, Neurosurgery, and Psychiatry 23, 56–62.
CA Hoogduin , HJ Duivenvoorden (1988). A decision model in the treatment of obsessive-compulsive neuroses. British Journal of Psychiatry 152, 516–521.
JD Huppert , HB Simpson , K Nissenson , M Liebowitz , EB Foa (2009). Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls. Depression and Anxiety 26, 39–45.
D Jacobson , A Wu , J Feinberg (2003). Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease. Journal of Clinical Epidemiology 56, 874–879.
GP Keijsers , CA Hoogduin , CP Schaap (1994). Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. British Journal of Psychiatry 165, 781–786.
PT Lelliott , HF Noshirvani , M Basoglu , IM Marks , WO Monteiro (1988). Obsessive-compulsive beliefs and treatment outcome. Psychological Medicine 18, 697–702.
D Mataix-Cols , IM Marks , JH Greist , KA Kobak , L Baer (2002). Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychotherapy and Psychosomatics 71, 255–262.
S Saxena , KM Maidment , T Vapnik , G Golden , T Rishwain , RM Rosen , G Tarlow , A Bystritsky (2002). Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. Journal of Clinical Psychiatry 63, 21–27.
HB Simpson , EB Foa , MR Liebowitz , D Roth Ledley , JD Huppert , SP Cahill , D Vermes , AB Schmidt , EA Hembree , M Franklin , R Campeas , C Hahn , E Petkova (2008). A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. American Journal of Psychiatry 165, 621–630.
HB Simpson , JD Huppert , E Petkova , EB Foa , MR Liebowitz (2006). Response versus remission in obsessive-compulsive disorder. Journal of Clinical Psychiatry 67, 269–276.
G Steketee , DL Chambless , GQ Tran (2001). Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Comprehensive Psychiatry 42, 76–86.
G Steketee , LJ Shapiro (1995). Predicting behavioral treatment outcome for agoraphobia and obsessive compulsive disorder. Clinical Psychology Review 15, 317–346.
SE Stewart , C-H Yen , DE Stack , MA Jenike (2006). Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment. Journal of Psychiatric Research 40, 511–519.
EA Storch , LJ Merlo , MJ Larson , GR Geffken , HD Lehmkuhl , ML Jacob , TK Murphy , WK Goodman (2008). Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 47, 583–592.
NH Tenneij , HJ van Megen , DA Denys , HG Westenberg (2005). Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. Journal of Clinical Psychiatry 66, 1169–1175.
DF Tolin , N Maltby , GJ Diefenbach , SE Hannan , P Worhunsky (2004). Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial. Journal of Clinical Psychiatry 65, 922–931.
MM Weissman , S Bothwell (1976). Assessment of social adjustment by patient self-report. Archives of General Psychiatry 33, 1111–1115.